Rockwell Medical Q3 net sales fall steeper-than-expected 44% as largest customer leaves

Reuters11-12
<a href="https://laohu8.com/S/RMTI">Rockwell Medical</a> Q3 net sales fall steeper-than-expected 44% as largest customer leaves

Overview

  • Rockwell Medical Q3 net sales fell 44% yr/yr, missing analyst expectations

  • Company achieved profitability on an adjusted EBITDA basis for Q3 2025

  • Rockwell Medical's cash position increased to $23.7 mln at September 30, 2025

Outlook

  • Rockwell Medical reiterates 2025 net sales guidance of $65 mln to $70 mln

  • Company expects 2025 gross margin between 16% and 18%

  • Rockwell Medical projects 2025 adjusted EBITDA between ($0.5) mln and $0.5 mln

Result Drivers

  • CUSTOMER LOSS - Net sales decreased due to largest customer transitioning to another supplier

  • NEW AGREEMENTS - Co signed new long-term product purchasing agreements with medical centers and hospital systems

  • OPERATIONAL EFFICIENCY - Co focused on right-sizing organization to enhance operational efficiency and support growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Miss

$15.93 mln

$16.20 mln (2 Analysts)

Q3 EPS

-$0.05

Q3 Net Income

-$1.75 mln

Q3 Gross Profit

$2.27 mln

Q3 Operating Income

-$1.58 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Rockwell Medical Inc is $4.00, about 73.8% above its November 11 closing price of $1.05

Press Release: ID:nBw2ygMNSa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment